BridgeMD
Tests treatment safety and results for Obesity
Official title Efficacy and Safety of Attapulgite in Patients With Obesity: An Exploratory Clinical Trial
ClinicalTrials.gov ID: NCT07103382
What this study is testing
- What it's testing
- To explore the safety and efficacy of attapulgite in the treatment of obese individuals or overweight/obese individuals with type 2 diabetes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Obese individuals:
- Aged 18-60 years, regardless of sex/gender
- BMI≥28.0kg/m2 Overweight or obese individuals with type 2 diabetes:
- Aged 18-60 years, regardless of sex/gender
- BMI≥24.0kg/m2
You likely can't join if
- Type 1 diabetes, monogenic diabetes, or diabetes due to pancreatic injury or other secondary diabetes
- Severe diabetic complications within three months before the study initiation, including severe hypoglycemia, diabetic ketoacidosis, or infections
- Use of weight-affecting products within the past three months or planned use during the study
- Weight fluctuation \>5 kg or \>10% within the past three months
- Obesity or overweight due to endocrine disorders (such as thyroid dysfunction or Cushing's syndrome)
- Uncontrolled hypertension, severe cardiac/hepatic/renal dysfunction
See the full eligibility criteria
- Obese individuals:
- Aged 18-60 years, regardless of sex/gender
- BMI≥28.0kg/m2 Overweight or obese individuals with type 2 diabetes:
- Aged 18-60 years, regardless of sex/gender
- BMI≥24.0kg/m2
- HbA1c ≥7.0% and ≤10.0% or the fasting blood glucose ≥7.0 mmol/l and ≤ 13.3 mmol/l at screening
- Stable diabetes treatment for at least 6 months or more
- Type 1 diabetes, monogenic diabetes, or diabetes due to pancreatic injury or other secondary diabetes
- Severe diabetic complications within three months before the study initiation, including severe hypoglycemia, diabetic ketoacidosis, or infections
- Use of weight-affecting products within the past three months or planned use during the study
- Weight fluctuation \>5 kg or \>10% within the past three months
- Obesity or overweight due to endocrine disorders (such as thyroid dysfunction or Cushing's syndrome)
- Uncontrolled hypertension, severe cardiac/hepatic/renal dysfunction
- History of gastrointestinal surgery (such as cholecystectomy) within the past year or non-gastrointestinal surgery within six months, or prior bariatric surgery
- Chronic gastrointestinal disorders (such as recurrent constipation, celiac disease, or food intolerances) or any condition impairing digestion/absorption function
- History of malignant tumors within five years, regardless of whether there is recurrence or metastasis and severe immune dysfunction (such as malignant tumors, HIV/AIDS, immunodeficiency diseases)
- Use of probiotics, prebiotics, or antibiotics within three months prior to enrollment, or alcohol abuse; Consumption of yogurt within two weeks before the study or during the trial period; History of psychiatric or...
- Pregnancy, lactation, or plans for pregnancy during the study
- Participation in other clinical trials within the past three months
- Any condition that in the judgement of the investigator precludes participation
The study team makes the final eligibility decision.
Where it's taking place
- Changsha, Hunan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Changsha, Hunan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.